Please login to the form below

Not currently logged in
Email:
Password:

Aerocrine

This page shows the latest Aerocrine news and features for those working in and with pharma, biotech and healthcare.

Circassia slumps as cat allergy vaccine fails late-stage trial

Circassia slumps as cat allergy vaccine fails late-stage trial

drugs and novel combinations gained through its acquisitions of Aerocrine and Prosonix last year.

Latest news

  • Allergy specialist Circassia buys asthma firms Allergy specialist Circassia buys asthma firms

    Allergy specialist Circassia buys asthma firms. British-based company acquires Sweden’ s Aerocrine and privately held Prosonix. ... Circassia will pay £139m ($219m) for Aerocrine and up to £100m for Prosonix.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics